IP Library Assignment 029069/0524
Patent Assignment
Reel/Frame 029069/0524

Assignment of Assignor's Interest

Recorded: 2012-10-03 Pages: 3
Assignor
ASTRAZENECA CANADA INC.
Executed: 2012-04-13
Assignee
ASTRAZENECA AB
SE-151 85, SODERTALJE, SWEDEN
Covered Property (1)
Benzoimidazole Compounds and Uses Thereof
Patent: 8,530,467 →
Application: 13/472,825 →
Publication: US 2012/0289504
Related Assignments (8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 3, 2012
From: CANTIN, LOUIS-DAVID; LUO, XUEHONG; TOMASZEWSKI, MIROSLAW JERZY
To: ASTRAZENECA CANADA INC.
Reel/Frame 029069/0496 →
Assignment of Assignor's Interest Dec 21, 2012
From: ASTRAZENECA AB
To: NEOMED INSTITUTE
Reel/Frame 029518/0326 →
Assignment of Assignor's Interest Aug 24, 2022
From: NEOMED INSTITUTE
To: BELLUS HEALTH COUGH INC.
Reel/Frame 060886/0325 →
Assignment of Assignor's Interest Aug 9, 2023
From: BELLUS HEALTH INC.
To: 14245563 CANADA INC.
Reel/Frame 065117/0909 →
Merger Aug 9, 2023
From: BELLUS HEALTH COUGH INC.
To: BELLUS HEALTH INC.
Reel/Frame 064531/0830 →
Assignment of Assignor's Interest Jan 19, 2024
From: 14245563 CANADA INC.
To: ID BIOMEDICAL CORPORATION OF QUEBEC
Reel/Frame 066353/0331 →
Assignment of Assignor's Interest Jan 19, 2024
From: ID BIOMEDICAL CORPORATION OF QUEBEC
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
Reel/Frame 066353/0356 →
Change of Address Apr 16, 2025
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
Reel/Frame 071351/0192 →